…Introduction Interstitial lung disease (ILD) is a common and severe complication of systemic sclerosis (SSc)…
interstitial lung disease (ILD)
This disease is selected. Its supporting articles are shown below.
Articles mentioning interstitial lung disease (ILD)
79 articles · page 4 of 7…Introduction Interstitial lung disease (ILD) is the leading cause of death in systemic sclerosis (SSc). Litt…
…able to characterise myocardial tissue for oedema and fibrosis. Interstitial lung disease (ILD) is a risk factor for pHI but the temporal relationship between …
…cular damage contributes to various cutaneous manifestations in systemic sclerosis (SSc). Concomitant macroangiopathy may also occur, potentially leadin…
…y treatment for interstitial lung disease (ILD) associated with systemic sclerosis (SSc) and is an option for cutaneous fibrosis. However, its use in pa…
…tial lung disease (ILD).Material and Methods The Western Sweden Systemic Sclerosis Project (WESST) is a longitudinal cohort study of SSc patients …
… cumulative dose of RTX. RTX is more effective in patients with systemic sclerosis and presence of anti-topoisomerase-1 antibodies.…
…Ds with evidence of efficacy for the treatment of patients with systemic sclerosis (SSc) with progressive disease non-responsive to csDMARDs. The aim of…
…l lung disease (ILD) and potential benefits on skin fibrosis in systemic sclerosis (SSc). This study aims to evaluate the safety and effectiveness of TC…
… EUSTAR centers 254 and 255.Results A total of 60 patients with systemic sclerosis (SSc) were included (diffuse cutaneous: 46.7%; limited cutaneous: 53.…
…Introduction Juvenile systemic sclerosis(jSSc) is an orphan disease with a prevalence of 3 in 1 000 000 …
…Introduction Differences between male and female patients with systemic sclerosis (SSc) have been investigated in several international cohort studies …